Merck & Co., Inc. (MRK) financial statements and ratios from SEC XBRL: revenue $65.01B (TTM), net margin 28.1%, revenue growth 5.1% YoY, P/E 115.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $65.01B |
| Net Margin | 28.1% |
| Revenue Growth (YoY) | 5.1% |
| EPS Growth (YoY) | -130.7% |
| FCF Growth (YoY) | 229.9% |
| P/E Ratio | 115.7 |
| EV / EBITDA | 45.2 |
| Price / Book | 8.74 |
| Price / Sales | 5.51 |
| FCF Yield | 3.7% |
| DCF Value (model) | $62.30 |
| DCF Upside vs Price | -58.1% |
| Altman Z-Score | 4.49 (safe) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
MRK overview · MRK earnings · MRK KPIs · MRK investor relations · MRK ownership · MRK peers · MRK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.